Disaster Recovery National Dislocated Worker Grants to Address the Opioid Crisis
ID: 345349Type: Posted
Overview

Buyer

Employment and Training Administration (DOL-ETA)

Award Range

$0 - $100M

Eligible Applicants

Others

Funding Category

Employment, Labor and Training

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/345349
Timeline
    Description

    The Employment and Training Administration of the U.S. Department of Labor is offering National Dislocated Worker Grants aimed at addressing the opioid crisis through disaster recovery initiatives. Applicants are required to provide detailed proposals that specify the state or tribal entity, project name, funding request, and projected participant numbers, while also justifying the selection of affected communities and detailing the types of disaster relief employment and training services to be provided. This funding opportunity, with an estimated total program funding of $100 million and an award ceiling of $100 million for up to 50 awards, emphasizes a coordinated response to mitigate the impacts of the opioid crisis through targeted employment and training initiatives. Interested applicants must submit their applications electronically by October 31, 2024, and can direct inquiries to DOL-ETA-DWG@dol.gov for further information.

    Point(s) of Contact
    DOL-ETA-DWG@dol.gov
    Files
    Title
    Posted
    TEGL-4-18 Attachment A - Proposal Summary.doc
    TEGL-4-18.doc
    The U.S. Department of Labor's Employment and Training Administration seeks proposals for the National Health Emergency Disaster Recovery Dislocated Worker Grants aimed at addressing the needs created by the opioid crisis in various communities. Applicants are required to specify the state or tribal entity, project name, funding request, and projected participant numbers. The application must detail projected costs for various grant activities, including disaster relief employment wages, training services, and supportive services, while adhering to performance measures established under the Workforce Innovation and Opportunity Act (WIOA). The statement of need requires applicants to identify affected communities and justify their selection, while documentation to support these claims counts towards a ten-page limit. Collaboration with local officials and Workforce Development Boards is mandatory, along with submissions of letters of support from partners, including organizations focused on opioid impact. The applicant should detail disaster relief employment types and connect these to training activities, ensuring that supportive services address individual participant needs. Finally, strategies for recruiting and enrolling eligible participants must align with WIOA standards. Overall, this RFP emphasizes a coordinated response to mitigate the impacts of the opioid crisis through targeted employment and training initiatives while ensuring local stakeholder involvement and service provision tailored to community needs.
    Similar Opportunities
    Updated National Dislocated Worker Grant Program Guidance and Application Information
    Employment and Training Administration
    The Employment and Training Administration (ETA) of the U.S. Department of Labor is offering the Updated National Dislocated Worker Grant Program, aimed at providing financial assistance to dislocated workers affected by significant economic disruptions or disasters. This grant program includes two types of funding: Disaster Recovery DWGs, which support temporary employment for cleanup and recovery efforts, and Employment Recovery DWGs, which address workforce needs arising from mass layoffs. The program emphasizes the importance of aligning with state and local workforce strategies and requires applicants to demonstrate eligibility and justify funding requests. The estimated total program funding is $300 million, with awards ranging from $150,000 to $10 million, and applications are due by December 31, 2026. For further information, interested parties can contact Jenifer McEnery at DOL-ETA-DWG@dol.gov.
    Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity aimed at the development of medications to prevent and treat opioid and stimulant use disorders and overdose. This initiative seeks innovative preclinical and clinical research projects that can lead to FDA-approved therapies, focusing on areas such as prevention of substance use initiation, treatment adherence, and reduction of overdose risks. With a maximum funding amount of $3 million per year over a project period of five years, applicants are encouraged to submit proposals that demonstrate their capability to manage the research effectively, adhering to detailed application instructions. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for September 1, 2025.
    First Responders – Comprehensive Addiction and Recovery Act
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "First Responders – Comprehensive Addiction and Recovery Act," aimed at supporting first responders and key community members in administering emergency treatments for opioid overdoses. This program is designed to enhance the capacity of eligible entities, including states, local governments, and tribal organizations, to utilize approved drugs or devices for the rapid reversal of opioid overdoses, addressing a critical public health issue. With an estimated total program funding of $5.1 million and an expected 12 awards, interested applicants can reach out to Shannon Hastings at (240) 276-1869 or via email at DTPFRCARA@samhsa.hhs.gov for further information. The synopsis for this opportunity is anticipated to be posted on November 15, 2024, with no cost-sharing or matching requirements.
    Rural Opioid Technical Assistance Regional Centers
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a federal grant opportunity titled "Rural Opioid Technical Assistance Regional Centers." This program aims to establish regional centers of excellence that will provide training and technical assistance to combat opioid and stimulant misuse in rural communities. The initiative is crucial for addressing the growing health crisis related to substance abuse in these areas, with an estimated total program funding of $7,150,000 and the expectation of awarding 11 grants. Interested applicants, including public or nonprofit entities, states, Indian tribes, and health facilities, can reach out to Twyla Adams at (240) 276-1576 or via email at twyla.adams@samhsa.hhs.gov for further information. The opportunity is currently posted, with an estimated synopsis posting date of May 1, 2025.
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis" (RFA-DA-25-078), aimed at supporting research that transforms addiction treatment and care to combat the ongoing overdose crisis. This initiative encourages phased applications (R61/R33), where the R61 phase focuses on exploratory activities without the need for existing pilot data, while the R33 phase seeks to implement larger studies based on successful R61 milestones, emphasizing stigma-free and patient-centered approaches. With up to $10 million allocated for FY2026 and a maximum award period of six years, applicants must include a Plan for Enhancing Diverse Perspectives (PEDP) to ensure inclusivity, and applications are to be submitted through Grants.gov by the closing date of March 20, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis" (RFA-DA-23-054), aimed at supporting innovative research that bridges the gap between research findings and practical applications to combat the opioid overdose crisis. This initiative emphasizes the need for stigma-free, patient-centered care systems and focuses on understudied areas related to overdose prevention, requiring applicants to present preliminary data for significant projects within a maximum project period of five years and a budget of up to $750,000 in direct costs annually. The funding reflects a commitment to addressing health disparities and promoting effective addiction treatment and recovery solutions, with applications evaluated based on significance, innovation, feasibility, and stakeholder engagement. Interested applicants should note that the application deadline is March 20, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Rural Communities Opioid Response Program – Northern Border Rural Workforce
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is offering a federal grant opportunity titled the Rural Communities Opioid Response Program – Northern Border Rural Workforce, aimed at enhancing the behavioral health workforce in rural areas of Maine, New Hampshire, New York, and Vermont. This initiative seeks to improve healthcare access by funding projects that train and place behavioral health professionals, requiring applicants to form networks of at least four entities, with half located in the target service area. With an estimated total program funding of $3.2 million and a maximum award ceiling of $400,000, the program emphasizes sustainable solutions to address the critical shortage of mental health professionals in these regions, with applications due by April 11, 2025. Interested applicants can reach out to Caitlin Dunn at ruralopioidresponse@hrsa.gov for further information.
    Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Chemical Countermeasures Research Program (CCRP) Initiative, aimed at supporting research on the harmful effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids, such as fentanyl and carfentanil. This initiative seeks to advance understanding of both immediate and delayed health impacts associated with these substances, emphasizing innovative research into toxicity mechanisms and the development of new therapeutic strategies. The program will provide up to four grants, with a maximum award of $300,000 annually over a potential five-year period, totaling an estimated $2 million in funding. Interested applicants, including various educational and nonprofit institutions, must submit their proposals by November 18, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis," aimed at supporting research that translates findings into practical solutions for addressing the overdose crisis. This initiative encourages applications from a diverse range of organizations, including educational institutions and nonprofits, with a focus on developing stigma-free, patient-centered systems for addiction recovery and improving the quality of addiction treatment services. The NIH plans to commit approximately $10 million to fund grants, with an expected award ceiling of $750,000 for up to 12 awards, and applications will be accepted starting February 20, 2025, with a closing date of March 20, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-077.html.
    Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is offering a funding opportunity for the development of medications aimed at preventing and treating substance use disorders (SUDs) and overdose. This initiative is structured into two phases: the UG3 phase focuses on achieving specific milestones within a two-year period, while the UH3 phase extends support for an additional three years for projects that successfully meet the UG3 milestones. Given the urgent need for effective treatments in light of rising overdose deaths, particularly from synthetic opioids and stimulants, this funding opportunity emphasizes innovative research methodologies and the effective application of existing medications. Interested applicants can seek funding of up to $3 million annually for a maximum of five years, with applications due by August 11, 2025. For further inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-329.html.